We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $77.1B
1-Year Est. Return 42.89%
This Fund
S&P 500
This Quarter Est. Return
+6.09%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$22B
AUM Growth
+$103K
Cap. Flow
-$916M
Cap. Flow %
-4.16%
Top 10 Hldgs %
10.55%
Holding
2,302
New
567
Increased
501
Reduced
537
Closed
688

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$168M
2
CNP icon
CenterPoint Energy
CNP
+$151M
3
NFLX icon
Netflix
NFLX
+$132M
4
EFX icon
Equifax
EFX
+$132M
5
SRE icon
Sempra
SRE
+$122M

Sector Composition

Rank Sector Weight
1 Financials 14.98%
2 Technology 10.51%
3 Consumer Discretionary 10.34%
4 Industrials 8.24%
5 Healthcare 7.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLDR
2176
CALL
DELISTED
Cloudera, Inc.
CLDR
-380,000
Closed -$5.18M
WRI
2177
DELISTED
Weingarten Realty Investors
WRI
-31,199
Closed -$961K
HOME
2178
DELISTED
At Home Group Inc.
HOME
-44,893
Closed -$1.58M
CATM
2179
PUT
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
-115,000
Closed -$2.78M
CMD
2180
DELISTED
Cantel Medical Corporation
CMD
-9,586
Closed -$943K
GNMK
2181
DELISTED
GenMark Diagnostics, Inc
GNMK
-11,740
Closed -$75K
FPRX
2182
DELISTED
Five Prime Therapeutics, Inc.
FPRX
-34,268
Closed -$542K
ANH
2183
DELISTED
Anworth Mortgage Asset Corporation
ANH
-67,967
Closed -$338K
QEP
2184
DELISTED
QEP RESOURCES, INC.
QEP
-12,687
Closed -$156K
OXFD
2185
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
-15,748
Closed -$203K
EIGI
2186
DELISTED
Endurance International Group Holdings, Inc.
EIGI
-42,384
Closed -$422K
ARA
2187
DELISTED
American Renal Associates Holdings, Inc
ARA
-12,387
Closed -$195K
CXO
2188
DELISTED
CONCHO RESOURCES INC.
CXO
-191,418
Closed -$26.5M
FIT
2189
DELISTED
Fitbit, Inc. Class A common stock
FIT
-48,528
Closed -$317K
DNKN
2190
DELISTED
Dunkin' Brands Group, Inc.
DNKN
-86,267
Closed -$5.96M
AMAG
2191
DELISTED
AMAG Pharmaceuticals
AMAG
-22,047
Closed -$430K
MR
2192
DELISTED
Montage Resources Corporation Common Stock
MR
-4,503
Closed -$108K
JCAP
2193
DELISTED
Jernigan Capital, Inc.
JCAP
-69,489
Closed -$1.32M
HTZ
2194
CALL
DELISTED
Hertz Global Holdings, Inc.
HTZ
-978,350
Closed -$13M
IMMU
2195
DELISTED
Immunomedics Inc
IMMU
-390,185
Closed -$9.24M
AXAS
2196
DELISTED
Abraxas Petroleum Corp
AXAS
-1,195
Closed -$69K
RST
2197
DELISTED
ROSETTA STONE INC
RST
-18,867
Closed -$302K
ONDK
2198
DELISTED
On Deck Capital, Inc.
ONDK
-44,655
Closed -$313K
ETFC
2199
DELISTED
E*Trade Financial Corporation
ETFC
-1,784,639
Closed -$105M
SHLO
2200
DELISTED
Shiloh Industries Inc
SHLO
-12,050
Closed -$105K

Similar funds

Balyasny Asset Management's Q3 2018 Portfolio in Review

As of Q3 2018, Balyasny Asset Management held 2,302 positions worth $22B, up 0% from $22B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Balyasny Asset Management withdrew a net $916M in Q3 2018, closing 688 positions and reducing 537 holdings. Its most notable exit was DuPont de Nemours, an estimated $144M position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 17% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Balyasny Asset Management opened a new position in Equifax worth $132M.

  • Balyasny Asset Management's largest Q3 2018 buy was Equifax: 1,013,016 shares worth $132M.
  • Balyasny Asset Management added most to Walt Disney in Q3 2018, an estimated $168M increase.
  • Balyasny Asset Management's biggest Q3 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $335M.
  • Balyasny Asset Management fully exited DuPont de Nemours in Q3 2018, selling an estimated $144M.
  • Balyasny Asset Management's ten largest holdings make up 11% of its $22B portfolio in Q3 2018.
  • Balyasny Asset Management opened 567 new positions and closed 688 in Q3 2018.
  • Balyasny Asset Management's portfolio value rose 0% quarter-over-quarter to $22B.

Based on Balyasny Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.